APOL1 and diabetes mellitus: To that end, we performed the largest genetic study of DME to date (a total of 1,502 cases and 5,603 controls) identifying two loci reaching genome-wide significance for risk of DME, one of which contains APOL1 and is estimated to account for approximately 5% of the risk of developing DME in African American patients with diabetes.